Vistagen TherapeuticsVTGN
13F holders, Q1 2025 (March 31)48holders −6
3new positions
9sold out
1famous investor
$2.45avg. 13F price*
At the end of Q1 2025, 48 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings, down 6 from Q4 2024. 3 opened new positions and 9 sold out. The largest holders were TCG Crossover Management, LLC ($6.7M), Stempoint Capital LP ($5.1M) and Nantahala Capital Management, LLC ($4.9M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vistagen Therapeutics Inc.
- CUSIP
- 92840H400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $69K |
| Exits | 9 | $1.2M |
All 13F filers, Q4 2024 → Q1 2025: 1,285,871 shares bought and 864,665 shares sold, net +421,206 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| TCG Crossover Management, LLC | 0.91% | No change | 2,676,580 | $6.7M |
| Stempoint Capital LP | 1.63% | Add +1.6% | 2,366,554 | $5.1M |
| Nantahala Capital Management, LLC | 0.41% | Reduce -0.2% | 1,978,492 | $4.9M |
| Vanguard Group Inc. | 0.00% | Reduce -3.0% | 1,960,172 | $4.9M |
| Commodore Capital LP | 0.29% | No change | 1,575,000 | $3.9M |
| Sphera Funds Management LTD. | 0.49% | Reduce -2.2% | 790,550 | $2.0M |
| JPMorgan Chase & Co. | 0.00% | Reduce -2.8% | 750,876 | $1.9M |
| Ikarian Capital, LLC | 0.49% | Add +675.2% | 601,703 | $1.5M |
| Diadema Partners LP | 1.13% | Add +27.9% | 565,975 | $1.4M |
| ADAR1 Capital Management, LLC | 0.21% | Add +246.4% | 420,765 | $1.1M |
| BlackRock, Inc. | 0.00% | Add +1.2% | 416,338 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +5.2% | 270,187 | $676K |
| Almitas Capital LLC | 0.21% | No change | 254,655 | $637K |
| Boothbay Fund Management, LLC | 0.02% | Add +693.5% | 177,858 | $445K |
| BML Capital Management, LLC | 0.30% | No change | 150,000 | $375K |
| AdvisorShares Investments LLC | 0.07% | Add +59.4% | 159,114 | $372K |
| Persistent Asset Partners Ltd | 0.27% | No change | 121,651 | $304K |
| Two Sigma Investments, LP | 0.00% | Reduce -18.1% | 112,507 | $281K |
| Blair William & Co. | 0.00% | Add +2.4% | 100,866 | $252K |
| State Street Corp. | 0.00% | No change | 96,858 | $242K |
| Susquehanna International Group, LLP | 0.00% | Reduce -32.5% | 64,781 | $162K |
| Morgan Stanley | 0.00% | Add +200.1% | 51,285 | $128K |
| Northern Trust Corp. | 0.00% | Add +6.4% | 48,093 | $120K |
| American Century Companies Inc. | 0.00% | Add +3.5% | 31,063 | $78K |
| Prosperity Wealth Management, Inc. | 0.03% | Reduce -5.6% | 27,600 | $69K |
| UBS Group AG | 0.00% | Reduce -80.5% | 25,779 | $64K |
| Renaissance Technologies | 0.00% | Reduce -70.4% | 24,800 | $62K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 23,302 | $58K |
| HighTower Advisors, LLC | 0.00% | No change | 20,828 | $52K |
| Kestra Advisory Services, LLC | 0.00% | Reduce -0.4% | 20,033 | $50K |
| Dimensional Fund Advisors LP | 0.00% | New | 17,545 | $44K |
| Two Sigma Advisers, LP | 0.00% | Reduce -10.8% | 10,732 | $27K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 10,088 | $25K |
| Group One Trading LLC | 0.00% | Reduce -94.3% | 5,569 | $14K |
| Osaic Holdings, Inc. | 0.00% | Reduce -51.9% | 5,494 | $14K |
| Simplex Trading, LLC | 0.00% | Reduce -7.4% | 2,402 | $6K |
| Cwm, LLC | 0.00% | Reduce -53.7% | 1,582 | $4K |
| Performa Ltd (US), LLC | 0.00% | No change | 1,000 | $3K |
| Royal Bank of Canada | 0.00% | Reduce -51.0% | 911 | $2K |
| Bank of America Corp. | 0.00% | Reduce -96.8% | 677 | $2K |
| MAI Capital Management | 0.00% | Reduce -5.4% | 576 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -0.4% | 471 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 286 | $715 |
| SJS Investment Consulting Inc. | 0.00% | No change | 100 | $250 |
| Jones Financial Companies LLLP | 0.00% | Reduce -71.4% | 80 | $207 |
| Fairman Group, LLC | 0.00% | No change | 29 | $86 |
| Citigroup Inc. | 0.00% | No change | 3 | $8 |
| Barclays PLC | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.